Losartan can cause severe transient anuria in patients with a solitary kidney and renovascular disease, highlighting the need for extreme caution when using angiotensin II receptor blockers in this setting.
Answers are grounded in this paper and cite their sources.
May warrant extreme caution with ARBs in solitary kidney and renovascular disease; hypothesis-generating for safety in this subgroup.
We report the case of a 70-year-old hypertensive man with a solitary kidney and chronic renal insufficiency who developed two episodes of transient anuria after losartan administration. He was hospitalized for a myocardial infarction with pulmonary edema, treated with high-dose diuretics. Due to severe systolic dysfunction losartan was prescribed. Surprisingly, the first dose of 50 mg of losartan resulted in a sudden anuria, which lasted eight hours despite high-dose furosemide and amine infusion. One week later, by mistake, losartan was prescribed again and after the second dose of 50 mg, the patient developed a second episode of transient anuria lasting 10 hours. During these two episodes, his blood pressure diminished but no severe hypotension was noted. Ultimately, an arteriography showed a 70-80% renal artery stenosis. In this patient, renal artery stenosis combined with heart failure and diuretic therapy certainly resulted in a strong activation of the renin-angiotensin system (RAS). Under such conditions, angiotensin II receptor blockade by losartan probably induced a critical fall in glomerular filtration pressure. This case report highlights the fact that the angiotensin II receptor antagonist losartan can cause serious unexpected complications in patients with renovascular disease and should be used with extreme caution in this setting.
No takes yet. Share an insight, caveat, or question.
Maillard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: